Global Biopharmaceuticals Market, By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulators, Other), Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial and Multi Compendial Laboratory Testing), Raw Material Type (Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support), Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Other) – Industry Trends and Forecast to 2029.
Global Biopharmaceuticals Market Analysis and Size
Over the next five years, the global biopharmaceutical market is projected to expand at a rapid pace owing to a rising research and development spending and increased incidence of cancer increases the demand for effective medicines. In 2020, the expected incidence of cancer cases in the United States was 2,281,658, with 612,390 fatalities, according to globocan 2020. Consequently, the presence of these growth determinants the market is being propelled forward and is projected to show substantial growth over the forecasted period. The market for biopharmaceutical is estimated to expand rapidly, providing various income opportunities.
- Global biopharmaceuticals market was valued at USD 350.53 million in 2021 and is expected to reach USD 639.26 million by 2029, registering a CAGR of 7.80% during the forecast period of 2022-2029. The “monoclonal antibodies” accounts for the largest product type segment in the biopharmaceuticals market within the forecasted period owing to the exponential research and applications within the oncology department. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Biopharmaceuticals Market Definition
Biopharmaceuticals are medications used in medicine that are made by extracting proteins and nucleic acids directly from biological sources with the help of biotechnology. Most biopharmaceuticals are pharmaceutical products created from living organisms; transgenic organisms are genetically modified plants and animals, and this process is used to produce biopharmaceuticals; nevertheless, it is a contentious technology that is still in the trial phase.
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Million, Volumes in Units, Pricing in USD
By Product Type (Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulators, Other), Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial and Multi Compendial Laboratory Testing), Raw Material Type (Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial Methods (USP / EP / JP) Based Vendor Qualification Program Support), Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, Other)
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
Market Players Covered
Amgen Inc. (U.S), Lilly (U.S), Johnson & Johnson Private Limited (U.S), Sanofi (France), Abbott (U.S), AstraZeneca (U.K), Amgen Inc. (U.S), F. Hoffmann-La Roche Ltd., (Switzerland), bioMérieux (France), Novartis AG (Switzerland), Bristol-Myers Squibb Company (U.S), Novo Nordisk A/S (Denmark), Merck & Co., Inc. (U.S), GlaxoSmithKline Plc (U.K), Biogen (U.S), Bayer AG (Germany) and Pfizer Inc., (U.S)
Biopharmaceuticals Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Huge Demand For Biopharmaceuticals
The huge market demand for biopharmaceuticals due to the rising chronic diseases and growing geriatric population is the most significant factor driving the growth for this market. Moreover, the ability of biopharmaceuticals to address untreatable conditions is also expected to accelerate the overall growth of the market.
Furthermore, the expanding healthcare sector along with increasing awareness about the effectiveness and availability of the biopharmaceuticals among the population is also expected to cushions the market’s growth within the forecasted period. The growing efforts in the development of the biopharmaceutical industry are also projected to bolster the growth of the market.
- Growing Research and Investments To Generate Opportunities
Moreover, the accelerating focus on research and related investments are estimated to generate lucrative opportunities for the market. The increased investments by the market players in the research and development of the new drugs and their clinical trials along with the increased government investments to develop the biopharmaceutical industry will also further offer numerous growth opportunities for the market.
Restraints/Challenges Global Biopharmaceuticals Market
- High Investments
On the other hand, investment are very high within the market, which is expected to obstruct market growth.
- Regulatory Issues Generate Challenges
Also, the stringent regulatory issues are projected to challenge the biopharmaceuticals market in the forecast period of 2022-2029.
This biopharmaceuticals market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biopharmaceuticals market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Biopharmaceuticals Market
The emergence of COVID-19 has put a significant strain on healthcare systems. The biopharmaceuticals market was moderately affected by the pandemic. The imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, led to halt of various operations, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, limiting the market’s expansion. Researchers all over the world are working to find ways to deal with this growing burden. As a result, demand for monoclonal antibodies that target COVID-19 is expected to surpass supply. In July 2020, the Drugs Controller General of India (DCGI) approved Itolizumab (ALZUMAb), an anti-CD6 IgG1 monoclonal antibody from Biocon Ltd in India, for the emergency treatment of cytokine release syndrome in COVID-19-infected patients with acute respiratory distress syndrome.
Almost all biopharmaceutical companies in the region have been working to produce effective COVID-19 therapies during the current pandemic, which is projected to accelerate the growth of the market over the pandemic.
- In February 2021, Bristol Myers Squibb and The Rockefeller University have announced the signing of a definitive agreement under which Bristol Myers Squibb has been granted a worldwide exclusive licence to develop, manufacture, and market Rockefeller's novel monoclonal antibody ("mAb") duo treatment that neutralises the SARS-CoV-2 virus for COVID therapy or prevention. This innovative treatment combines two monoclonal antibodies (mAbs) that block the SARS-CoV-2 spike protein and neutralise the virus. The mAbs have been designed to be highly effective and stable, allowing them to stay in the bloodstream for longer periods of time. Preclinical research suggests that this could allow for effective treatment of numerous virus variations with a low-dose subcutaneous delivery, reducing the requirement for intravenous infusion and increasing access to the therapy.
Global Biopharmaceuticals Market Scope
The biopharmaceuticals market is segmented on the basis of product type, service, raw material type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Monoclonal Antibodies
- Recombinant Growth Factors
- Purified Proteins
- Recombinant Proteins
- Recombinant Hormone
- Synthetic Immunomodulators
On the basis of product type, the biopharmaceuticals market is segmented into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormone, vaccines, synthetic immunomodulators and other. Monoclonal antibodies are estimated to hold the largest market share owing to the exponential research and applications within the oncology department.
- Laboratory Testing
- Custom Testing / Customer Proprietary Testing
- Compendial and Multi Compendial Laboratory Testing
On the basis of service, the biopharmaceuticals market is segmented into laboratory testing, custom testing / customer proprietary testing, compendial and multi compendial laboratory testing.
Raw Material Type
- Formulation Excipients
- Active Pharmaceutical Ingredients (API)
- Compendial Methods (USP / EP / JP)
- Based Vendor Qualification Program Support
On the basis of raw material type, the biopharmaceuticals market is segmented into formulation excipients, active pharmaceutical ingredients (API), compendial methods (USP / EP / JP) based vendor qualification program support.
- Inflammatory and Infectious Diseases
- Autoimmune Disorders
- Metabolic Disorders
- Hormonal Disorders
- Cardiovascular Diseases
- Neurological Diseases
On the basis of application, the biopharmaceuticals market is bifurcated into oncology, inflammatory and infectious diseases, autoimmune disorders, metabolic disorders, hormonal disorders, cardiovascular diseases, neurological diseases and other.
Biopharmaceuticals Market Regional Analysis/Insights
The biopharmaceuticals market is analyzed and market size insights and trends are provided by country product type, service, raw material type, and application as referenced above.
The countries covered in the biopharmaceuticals market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the biopharmaceuticals market because of the strong hold of U.S. which raises the per capita health expenditure along with innovation and huge capital investments within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increasing research and development investment along with growth in rare disease diagnosis within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The biopharmaceuticals market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biopharmaceuticals market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biopharmaceuticals market. The data is available for historic period 2010-2020.
Competitive Landscape and Biopharmaceuticals Market Share Analysis
The biopharmaceuticals market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biopharmaceuticals market.
Some of the major players operating in the biopharmaceuticals market are Amgen Inc. (U.S), Lilly (U.S), Johnson & Johnson Private Limited (U.S), Sanofi (France), Abbott (U.S), AstraZeneca (U.K), Amgen Inc. (U.S), F. Hoffmann-La Roche Ltd., (Switzerland), bioMérieux (France), Novartis AG (Switzerland), Bristol-Myers Squibb Company (U.S), Novo Nordisk A/S (Denmark), Merck & Co., Inc. (U.S), GlaxoSmithKline Plc (U.K), Biogen (U.S), Bayer AG (Germany) and Pfizer Inc., (U.S) among others.
Research Methodology : Global Biopharmaceuticals Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-biopharmaceuticals-market
Customization Available : Global Biopharmaceuticals Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.